3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
7
OTHER
6
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Melanoma
2
Head and Neck Neoplasms
2
Uveal Melanoma
1
Urogenital Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcopenia
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Diseases
1
Neoplasms, Glandular and Epithelial
1
Gliosarcoma
1
Glioblastoma
1
Genital Neoplasms, Female
1
Endometrial Neoplasms
1
Efficacy, Team
1
Carcinoma, Ovarian Epithelial
1
Advanced Solid Tumours
1
Advanced Solid Tumor
1
Adrenocortical Carcinoma
1
Interventions
Melphalan
3
Interleukin-2
3
Nivolumab
2
Ipilimumab
2
pembrolizumab
1
entinostat
1
Tramadol
1
Ibuprofen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Uveal Melanoma
×
pembrolizumab
×
Clear all
NCT02697630
2023-12-08
PEMDAC
Vastra Gotaland Region
Phase 2
Completed
29 enrolled